Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in LLY — ELI LILLY & Co

CIK 1166588 NEW YORK, NY
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,153,247,243
+$393,639,553 QoQ
Shares Held
961,496
+16.4% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#76
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$4,477,420
CallShares
3,733
PutValue
$3,059,700
PutShares
2,551

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $4,776,233,341 across 18 Drug Manufacturers - General names. LLY ranks #1 (24.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		961,496 $1,153,247,243
2 ABBV
AbbVie Inc.
 3,055,271 $768,828,394
3 JNJ
Johnson & Johnson
 2,799,362 $710,953,967
4 AMGN
Amgen Inc
 1,321,585 $478,572,360
5 MRK
Merck & Co., Inc.
 3,130,937 $402,325,404
6 GILD
Gilead Sciences, Inc.
 2,536,332 $320,440,184
7 BMY
Bristol Myers Squibb Co
 5,492,542 $316,480,270
8 PFE
Pfizer Inc
 10,704,871 $257,773,293

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,153,247,243 961,496
2026-06-30 $3,059,700 2,551
2026-06-30 $4,477,420 3,733
2026-03-31 $1,950,787 2,121
2026-03-31 $4,056,143 4,410
2026-03-31 $759,607,690 825,867
2025-12-31 $4,355,613 4,053
2025-12-31 $2,625,387 2,443
2025-12-31 $762,158,828 709,196
2025-09-30 $1,149,841 1,507
2025-09-30 $1,760,241 2,307
2025-09-30 $363,097,203 475,881
2025-06-30 $1,177,839 1,511
2025-06-30 $650,414,887 834,368
2025-06-30 $444,308 570
2025-03-31 $705,642,637 854,382
2025-03-31 $1,097,593 1,329
2025-03-31 $330,323 400
2024-12-31 $530,851,904 687,632
2024-12-31 $785,124 1,017
2024-12-31 $1,093,152 1,416
2024-09-30 $934,625 1,055
2024-09-30 $747,687 844
2024-09-30 $629,016,514 709,999
2024-06-30 $773,181 854
2024-06-30 $643,125,818 710,338
2024-06-30 $576,708 637
2024-03-31 $408,417 525
2024-03-31 $589,301,588 757,496
2024-03-31 $873,638 1,123
2023-12-31 $150,366,545 257,954
2023-12-31 $299,030 513
2023-12-31 $608,559 1,044
2023-09-30 $438,290 816
2023-09-30 $250,297,208 465,990
2023-09-30 $230,957 430
2023-06-30 $149,110,315 317,946
2023-06-30 $173,049 369
2023-06-30 $177,741 379
2023-03-31 $181,990,621 529,936
2023-03-31 $22,321 65
2023-03-31 $139,770 407
2022-12-31 $35,485 97
2022-12-31 $432,417 1,182
2022-12-31 $170,610,947 466,354
2022-09-30 $84,187,729 260,361
2022-09-30 $18,429 57
2022-09-30 $370,553 1,146
2022-06-30 $343,357 1,059
2022-06-30 $7,132 22